2019 International Congress

Tuesday, September 24, 2019

1:45pm-3:15pm

Cough sensitivity and aspiration pneumonia in Parkinson’s disease

S. Tomita, T. Oeda, S. Takaya, M. Kohsaka, K. Park, A. Umemura, Y. Mori, T. Ishihara, S. Nomoto, M. Tahara, K. Yamamoto, H. Sawada (Kyoto, Japan)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease

Y. Li, M. Niu, J. Liu (Shanghai, China)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Daytime Sleepiness Effects on Motor Symptoms in De Novo Parkinson’s Disease

E. Bayram, R. Yilmaz, K. Longardner, M. Akbostanci, I. Litvan (La Jolla, CA, USA)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

DBS Programming In Tremor And Akinetic-Rigid Predominant Parkinson’s Disease

Z. Guduru, D. Ginjupally, T. Ali, N. El Seblani, J. Quintero, C. van Horne (Lexington, KY, USA)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

DCM extract of Scutellaria Pinnatifida modulate alpha-synuclein fibrillation and protects dopaminergic SH-SY5Y cells against rotenone

S. Parsafar, D. Morshedi, M. Mohammadi (Tehran, Islamic Republic of Iran)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Deciphering Corticobasal Syndrome: are clinical features and FDG-PET imaging capable of predicting amiloyd status?

J. Parmera, A. Coutinho, A. Neto, M. Aranha, C. Ono, C. Buchpiguel, R. Nitrini, E. Barbosa, S. Brucki (São Paulo, Brazil)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Deciphering the role of posttranslational modifications on α-synuclein aggregation and toxicity

T. Outeiro (Goettingen, Germany)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Deep Brain Stimulation (DBS) clinical impedance measurements of the Medtronic Clinician 8840 versus the Samsung Galaxy Tab S2 tablet interface

D. Caputo, S. Danish, E. Hargreaves (New Brunswick, NJ, USA)

Neurophysiology  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Deep Brain Stimulation as second line advanced treatment for PD after LCIG

A. Faust-Socher, F. Abu Ahmad, N. Giladi, A. Hilel, Y. Shapira, D. Klepikov, A. Ezra, L. Raif, T. Gurevich (Tel Aviv, Israel)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Deep Brain Stimulation for atypical tremors secondary to Neuroferritinopathy: Single center experience

S. Chandra, J. Randhawa, M. Schiess (Houston, TX, USA)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3